The Week of

Otsuka Pharmaceutical announced it is acquiring Transcend Therapeutics in a deal worth up to $1.225 billion, gaining control of its lead asset, TSND-201, which is an MDMA analog being developed for PTSD and other psychiatric conditions.

The drug is designed to enhance neuroplasticity without the hallucinogenic effects typically associated with MDMA, and has already shown positive Phase 2 results, with a Phase 3 trial now underway. 

This is Otsuka’s second acquisition of a psychedelics company. The first was Mindset Pharma, which it acquired in 2024 for $59 million. Here’s more: https://substack.com/home/post/p-192853023.

Scientists at Lund University developed a new AI model that can detect multiple neurodegenerative diseases from a single blood sample by analyzing protein patterns as biological “fingerprints.” 

Instead of testing for one disease at a time, the system evaluates overlapping conditions simultaneously and has shown better predictive power for cognitive decline than traditional diagnostics. 

The findings suggest these diseases are not single conditions but biologically diverse categories, and point toward a more precise, biology-driven approach to diagnosis and drug development. Check it out: https://www.nature.com/articles/s41591-026-04303-y

A new study from Definium Therapeutics has found that generalized anxiety disorder (GAD) is becoming more widespread and burdensome in the U.S., with diagnosed prevalence rising from 5.4% in 2020 to 6.6% in 2023 and affecting over 1 in 10 adults over that three-year period.

The research, based on real-world healthcare data, also shows a steady flow of new cases each year and highlights strong links between GAD and major depressive disorder, particularly among women.

Overall, the findings point to a growing mental health crisis with significant unmet need, underscoring the urgency for better diagnosis, access to care, and more effective treatments in a space that has seen little innovation in decades. Here’s more: https://www.biospace.com/press-releases/new-definium-therapeutics-study-published-in-the-journal-of-mood-and-anxiety-disorders-reveals-increasing-prevalence-and-burden-of-generalized-anxiety-disorder-in-the-united-states

Did you know that a paralyzed man is now creating music using only his thoughts?

In a groundbreaking experiment, 69-year-old Galen Buckwalter, who has six brain implants, can translate neural activity into musical tones, essentially turning his brain into an instrument. 

The technology, part of a brain-computer interface study, decodes signals tied to imagined movements and converts them into sound, allowing him to compose and even record music. 

While these implants are typically designed to restore movement and communication, this case highlights a new frontier: using brain tech not just for function, but for creativity and self-expression. Check it out: https://www.wired.com/story/meet-the-man-making-music-with-his-brain-implant/